Purple Chrysanthemum (Camellia sinensis)

Purple Chrysanthemum (Camellia sinensis) is a tea cultivar selectively bred or naturally occurring for elevated anthocyanin pigmentation, which gives the leaves their distinctive purple hue. These anthocyanins, alongside standard green tea catechins such as EGCG, are the primary bioactive compounds thought to confer antioxidant and anti-inflammatory activity.

Origin & History

Purple Chrysanthemum (Camellia sinensis) does not exist as a recognized cultivar variant - this appears to be a conflation of two distinct plants: Chrysanthemum morifolium (purple chrysanthemum flowers) and Camellia sinensis (the tea plant). Camellia sinensis is an evergreen shrub native to East Asia that produces white to pink flowers, not purple ones, and is cultivated globally for tea production from its leaves.

Historical & Cultural Context

Camellia sinensis has been used in Traditional Chinese Medicine since ~2700 BCE for digestion and longevity via leaf infusions. However, no historical use of 'Purple Chrysanthemum' tea cultivar exists, as C. sinensis flowers are white/pink, not purple. Purple chrysanthemums in TCM refer to Ju Hua (Chrysanthemum morifolium), an unrelated plant used for eye conditions.

Health Benefits

• No clinical evidence exists for 'Purple Chrysanthemum (Camellia sinensis)' as it is not a documented entity
• Standard Camellia sinensis (tea) contains catechins with antioxidant properties - general tea studies exist but no purple variant data
• Traditional Chinese Medicine uses actual purple chrysanthemums (Ju Hua) for eye inflammation - unrelated to tea plants
• General tea polyphenols may support metabolic health - no specific evidence for queried ingredient
• No human clinical trials or meta-analyses found for this non-existent cultivar

How It Works

The anthocyanins in purple Camellia sinensis cultivars act as free-radical scavengers by donating hydrogen atoms to neutralize reactive oxygen species, and may inhibit NF-κB signaling to reduce pro-inflammatory cytokine expression. EGCG, a catechin present in standard and purple-leaf tea, inhibits the enzyme catechol-O-methyltransferase (COMT) and modulates PI3K/Akt pathways relevant to cell survival and metabolism. The synergistic presence of both anthocyanins and catechins may produce additive antioxidant capacity as measured by ORAC and DPPH radical scavenging assays, though this has not been confirmed in clinical trials for this specific cultivar.

Scientific Research

No human clinical trials, RCTs, or meta-analyses exist for 'Purple Chrysanthemum (Camellia sinensis)' as this cultivar is not recognized in botanical or medical literature. Search results provided no PubMed PMIDs for this query. General Camellia sinensis studies on catechins and polyphenols exist but are unrelated to any purple variant.

Clinical Summary

No published randomized controlled trials or observational studies have been conducted specifically on Purple Chrysanthemum (Camellia sinensis) as a named cultivar, making direct clinical evidence absent. General research on Camellia sinensis green tea, including meta-analyses of 10–50+ RCTs with thousands of participants, supports modest reductions in LDL cholesterol (approximately 2–5 mg/dL) and fasting glucose with regular consumption. Studies on anthocyanin-rich teas broadly suggest improved endothelial function and reduced oxidative stress markers, but these findings cannot be directly extrapolated to this specific cultivar without cultivar-specific phytochemical profiling data. Overall, the evidence base is preliminary and extrapolated; consumers should treat efficacy claims with caution until dedicated research is available.

Nutritional Profile

As 'Purple Chrysanthemum (Camellia sinensis)' is not a standardized or documented cultivar, nutritional data is extrapolated from known purple-leafed Camellia sinensis varieties (e.g., 'Purple Rain' from Kenya, TRFK 306/1) and standard green/white tea compositions. Purple-pigmented Camellia sinensis leaves contain elevated anthocyanins (primarily cyanidin-3-glucoside and delphinidin-3-glucoside) estimated at 1.5–4.5 mg/g dry weight, significantly higher than standard green tea (<0.1 mg/g). Catechins remain the dominant bioactive class: EGCG (epigallocatechin gallate) approximately 50–150 mg per 8 oz brewed cup, EGC ~15–80 mg, ECG ~10–45 mg, EC ~10–30 mg. Total polyphenols estimated at 200–400 mg per 8 oz serving. Caffeine content approximately 20–45 mg per 8 oz cup, lower than standard black tea. L-theanine approximately 5–25 mg per serving, supporting calm alertness. Micronutrients per 8 oz brewed tea include manganese (~0.5 mg, ~22% DV), potassium (~90 mg), fluoride (~0.2 mg), and trace zinc, magnesium, and calcium. Vitamin K is present in leaf material (~50 µg/g dry leaf) but largely absent in brewed liquid. Chlorophyll derivatives (chlorophyll a/b) present in leaf at ~1–3 mg/g dry weight. Protein content in brewed tea is negligible (<0.1 g per cup); dry leaf material contains approximately 15–20% protein by dry weight, largely non-bioavailable via standard brewing. Fiber is absent in liquid form; dry leaf contains ~35–40% total dietary fiber. Bioavailability note: catechin absorption is 1.5–5% of ingested dose due to gut metabolism and protein binding; anthocyanin bioavailability is low (~1–2%) but metabolites persist in circulation. Brewing temperature (70–85°C) and steep time (2–3 minutes) significantly influence catechin and anthocyanin extraction efficiency.

Preparation & Dosage

No clinically studied dosages exist for 'Purple Chrysanthemum (Camellia sinensis)' due to lack of recognition as a real cultivar. Standard Camellia sinensis leaf extracts (green tea standardized to 50% polyphenols/EGCG) are studied at 200-400 mg/day, but this is unrelated to any purple cultivar. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Not applicable - ingredient does not exist

Safety & Interactions

Purple Chrysanthemum tea, as a Camellia sinensis product, carries the same caffeine-related risks as standard green or black tea, including insomnia, elevated heart rate, and anxiety at high intakes (typically above 400 mg caffeine per day). EGCG at supplemental doses (above 800 mg/day) has been associated with hepatotoxicity in rare case reports, though brewed tea at normal serving sizes poses minimal risk. The catechins in Camellia sinensis can reduce iron absorption from non-heme sources and may interact with anticoagulants such as warfarin due to vitamin K content in tea leaves. Pregnant individuals are advised to limit caffeine intake to under 200 mg per day; high-dose tea extracts are not recommended during pregnancy or lactation.